The Journal of Allergy and Clinical Immunology
Volume 122, Issue 2 , Pages 225-235 , August 2008

Airway injury as a mechanism for exercise-induced bronchoconstriction in elite athletes

  • Sandra D. Anderson, PhD, DSc

      Affiliations

    • Corresponding Author InformationReprint requests: Sandra D. Anderson, PhD, DSc, Department of Respiratory and Sleep Medicine, 11 West, Royal Prince Alfred Hospital, 50 Missenden Road, Camperdown, New South Wales 2050, Australia.
    • ,
  • Pascale Kippelen, PhD

Received 1 April 2008 ,Revised 30 April 2008 ,Accepted 1 May 2008.

References 

  1. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is …. J Allergy Clin Immunol. 2000;106:453–459
  2. Chen WY, Horton DJ. Heat and water loss from the airways and exercise-induced asthma. Respiration. 1977;34:305–313
  3. Strauss RH, McFadden ER, Ingram RH, Deal EC, Jaeger JJ, Stearns D. Influence of heat and humidity on the airway obstruction induced by exercise in asthma. J Clin Invest. 1978;61:433–440
  4. Anderson SD, Daviskas E, Schoeffel RE, Unger SF. Prevention of severe exercise-induced asthma with hot humid air. Lancet. 1979;2:629
  5. Anderson SD, Schoeffel RE, Black JL, Daviskas E. Airway cooling as the stimulus to exercise-induced asthma—a re-evaluation. Eur J Respir Dis. 1985;67:20–30
  6. Aitken ML, Marini JJ. Effect of heat delivery and extraction on airway conductance in normal and in asthmatic subjects. Am Rev Respir Dis. 1985;131:357–361
  7. Argyros GJ, Phillips YY, Rayburn DB, Rosenthal RR, Jaeger JJ. Water loss without heat flux in exercise-induced bronchospasm. Am Rev Respir Dis. 1993;147:1419–1424
  8. Anderson SD. Is there a unifying hypothesis for exercise-induced asthma?. J Allergy Clin Immunol. 1984;73:660–665
  9. McFadden ER. Hypothesis: exercise-induced asthma as a vascular phenomenon. Lancet. 1990;1:880–883
  10. McFadden ER, Lenner KA, Strohl KP. Postexertional airway rewarming and thermally induced asthma. J Clin Invest. 1996;78:18–25
  11. Rouadi P, Baroody FM, Abbott D, Naureckas E, Solway J, Naclerio RM. A technique to measure the ability of the human nose to warm and humidify air. J Appl Physiol. 1999;87:400–406
  12. Nicolai T, Mutius EV, Reitmeir P, Wjst M. Reactivity to cold-air hyperventilation in normal and in asthmatic children in a survey of 5,697 schoolchildren in southern Bavaria. Am Rev Respir Dis. 1993;147:565–572
  13. O'Cain CF, Dowling NB, Slutsky AS, Hensley MJ, Strohl KP, McFadden ER, et al. Airway effects of respiratory heat loss in normal subjects. J Appl Physiol. 1980;49:875–880
  14. Daviskas E, Gonda I, Anderson SD. Local airway heat and water vapour losses. Respir Physiol. 1991;84:115–132
  15. Chen BT, Yeates DB. Ion transport and regulation of respiratory tract fluid output in dogs. J Appl Physiol. 2001;90:821–831
  16. Chen BT, Yeates DB. Differentiation of ion-associated and osmotically driven water transport in canine airways. Am J Respir Crit Care Med. 2000;162:1715–1722
  17. Folkesson HG, Matthay MA, Frigeri A, Verkman AS. Transepithelial water permeability in microperfused distal airways. Evidence for channel-mediated water transport. J Clin Invest. 1996;97:664–671
  18. Button B, Picher M, Boucher RC. Differential effects of cyclic and constant stress on ATP release and mucociliary transport by human airway epithelia. J Physiol. 2007;580:577–592
  19. Yoshikawa T, Shoji S, Fujii T, Kanazawa H, Kudoh S, Hirata K, et al. Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur Respir J. 1998;12:879–884
  20. Jonasson G, Carlsen KH, Hultquist C. Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren. Pediatr Allergy Immunol. 2000;11:120–125
  21. Hofstra WB, Neijens HJ, Duiverman EJ, Kouwenberg JM, Mulder PG, Kuethe MC, et al. Dose-response over time to inhaled fluticasone propionate: treatment of exercise- and methacholine-induced bronchoconstriction in children with asthma. Pediatr Pulmonol. 2000;29:415–423
  22. Subbarao P, Duong M, Adelroth E, Otis J, Obminski G, Inman M, et al. Effect of ciclesonide dose and duration of therapy on exercise-induced bronchoconstriction in patients with asthma. J Allergy Clin Immunol. 2006;117:1008–1013
  23. Duong M, Subbarao P, Adelroth E, Obminski G, Strinich T, Inman M, et al. Sputum Eosinophils and the response of exercise-induced bronchoconstriction to corticosteroid in asthma. Chest. 2008;133:404–411
  24. Provost-Craig MA, Arbour KS, Sestili DC, Chabalko JJ, Ekinci E. The incidence of exercise-induced bronchospasm in competitive figure skaters. J Asthma. 1996;33:67–71
  25. Mannix ET, Manfredi F, Farber MO. A comparison of two challenge tests for identifying exercise-induced bronchospasm in figure skaters. Chest. 1999;115:649–653
  26. Wilber RL, Rundell L, Szmedra L, Jenkinson DM, Im J, Drake SD. Incidence of exercise-induced bronchospasm in Olympic Winter Sport athletes. Med Sci Sports Exerc. 2000;32:732–737
  27. Anderson SD, Holzer K. Exercise-induced asthma: is it the right diagnosis in elite athletes?. J Allergy Clin Immunol. 2000;106:419–428
  28. Sue-Chu M, Larsson L, Bjermer L. Prevalence of asthma in young cross-country skiers in central Scandinavia: differences between Norway and Sweden. Respir Med. 1996;90:99–105
  29. Pisarri TE, Jonzon A, Coleridge HM, Coleridge JC. Vagal afferent and reflex responses to changes in surface osmolarity in lower airways in dogs. J Appl Physiol. 1992;73:2305–2313
  30. Dwyer TM, Farley JM. Mucus glycoconjugate secretion in cool and hypertonic solutions. Am J Physiol Lung Cell Mol Physiol. 1997;272:L1121–L1125
  31. Rundell KW, Im J, Mayers LB, Wilber RL, Szmedra L, Schmitz HR. Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc. 2001;33:208–213
  32. Sont JK, Booms P, Bel EH, Vandenbroucke JP, Sterk PJ. The severity of breathlessness during challenges with inhaled methacholine and hypertonic saline in atopic asthmatic subjects. The relationship with deep breath-induced bronchodilation. Am J Respir Crit Care Med. 1995;152:38–44
  33. Larsson K, Ohlsén P, Malmberg P, Rydström P-O, Ulriksen H. High prevalence of asthma in cross country skiers. BMJ. 1993;307:1326–1329
  34. Leuppi JD, Kuln M, Comminot C, Reinhart WH. High prevalence of bronchial hyperresponsiveness and asthma in ice hockey players. Eur Respir J. 1998;12:13–16
  35. Holzer K, Anderson SD, Douglass J. Exercise in elite summer athletes: challenges for diagnosis. J Allergy Clin Immunol. 2002;110:374–380
  36. Holzer K, Anderson SD, Chan H-K, Douglass J. Mannitol as a challenge test to identify exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003;167:534–547
  37. Brannan JD, Gulliksson M, Anderson SD, Chew N, Kumlin M. Evidence of mast cell activation and leukotriene release after mannitol inhalation. Eur Respir J. 2003;22:491–496
  38. Brannan JD, Gulliksson M, Anderson SD, Chew N, Seale JP, Kumlin M. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. Eur Respir J. 2006;27:944–950
  39. Gulliksson M, Palmberg L, Nilsson G, Ahlstedt S, Kumlin M. Release of prostaglandin D2 and leukotriene C in response to hyperosmolar stimulation of mast cells. Allergy. 2006;61:1473–1479
  40. Moloney ED, Griffin S, Burke CM, Poulter LW, O'Sullivan S. Release of inflammatory mediators from eosinophils following a hyperosmolar stimulus. Respir Med. 2003;97:1–5
  41. Barnes NC, Piper PJ, Costello JF. Comparative effects of inhaled leukotriene C4, leukotriene D4, and histamine in normal human subjects. Thorax. 1984;39:500–504
  42. Hardy CC, Robinson C, Tattersfield AE, Holgate ST. The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med. 1984;311:209–213
  43. Haby MM, Anderson SD, Peat JK, Mellis CM, Toelle BG, Woolcock AJ. An exercise challenge protocol for epidemiological studies of asthma in children: comparison with histamine challenge. Eur Respir J. 1994;7:43–49
  44. Backer V, Dirksen A, Bach-Mortensen N, Hansen KK, Laursen EM, Wendelboe D. The distribution of bronchial responsiveness to histamine and exercise in 527 children and adolescents. J Allergy Clin Immunol. 1991;88:68–76
  45. Ernst P, Ghezzo H, Becklake MR. Risk factors for bronchial hyperresponsiveness in late childhood and early adolescence. Eur Respir J. 2002;20:635–639
  46. Jones A, Bowen M. Screening for childhood asthma using an exercise test. Br J Gen Pract. 1994;44:127–131
  47. Sue-Chu M, Brannan JD, Anderson SD, Chew N, Bjermer L. Airway responsiveness to methacholine (Mch), adenosine 5-monophosphate (AMP), mannitol (Man), eucapnic voluntary hyperpnea (EVH) and sport specific field exercise challenge (Ex) in cross country ski athletes. Eur Respir J. 2002;20:410s
  48. Stensrud T, Mykland KV, Gabrielsen K, Carlsen KH. Bronchial hyperresponsiveness in skiers: field test versus methacholine provocation?. Med Sci Sports Exerc. 2007;39:1681–1686
  49. Langdeau J-B, Turcotte H, Bowie DM, Jobin J, Desgagné P, Boulet L-P. Airway hyperresponsiveness in elite athletes. Am J Respir Crit Care Med. 2000;161:1479–1484
  50. Potts J. Factors associated with respiratory problems in swimmers. Sports Med. 1996;21:256–261
  51. Potts J. Adverse respiratory health effects of competitive swimming: the prevalence of symptoms, illnesses and bronchial responsiveness to methacholine and exercise [MD thesis] Vancouver: University of British Columbia; 1994.
  52. Koskela H, Di Sciascio M, Anderson SD, Andersson M, Chan H-K, Gadalla S, et al. Nasal hyperosmolar challenge with a dry powder of mannitol in patients with allergic rhinitis. Evidence for epithelial cell involvement. Clin Exp Allergy. 2000;30:1627–1636
  53. Baraniuk JN, Ali M, Yuta A, Fang SY, Naranch K. Hypertonic saline nasal provocation stimulates nociceptive nerves, substance P release, and glandular mucous exocytosis in normal lumens. Am J Respir Crit Care Med. 1999;160:655–662
  54. Lazarowski ER, Tarran R, Grubb BR, van Heusden CA, Okada S, Boucher RC. Nucleotide release provides a mechanism for airway surface liquid homeostasis. J Biol Chem. 2004;279:36855–36864
  55. Sue-Chu M, Karjalainen E-M, Laitinen A, Larsson L, Laitinen LA, Bjermer L. Placebo-controlled study of inhaled budesonide on indices of airways inflammation in bronchoalveolar lavage fluid and bronchial biopsies in cross country skiers. Respiration. 2000;67:417–425
  56. Rundell KW, Spiering BA, Baumann JM, Evans TM. Bronchoconstriction provoked by exercise in a high-particulate-matter environment is attenuated by montelukast. Inhal Toxicol. 2005;17:99–105
  57. Fitch KD. β2-agonists at the Olympic Games. Clin Rev Allergy Immunol. 2006;31:259–268
  58. Anderson SD. Kippelen P. Exercise-induced bronchoconstriction: Pathogenesis. Curr Allergy Asthma Rep. 2005;5:116–122
  59. Greiff L, Andersson M, Erjefalt JS, Persson CGA, Wollmer P. Airway microvascular extravasation and luminal entry of plasma. Clin Physiol Funct Imaging. 2003;23:301–306
  60. Greiff L, Andersson M, Coman WB, Lindberg H, Marko-Varga G, Wallwork B, et al. Challenge-induced plasma exudation and mucinous secretion in human airways. Clin Physiol Funct Imaging. 2005;25:241–245
  61. Persson CG, Erjefalt JS, Andersson M, Greiff L, Svensson C. Extravasation, lamina propria flooding and lumenal entry of bulk plasma exudate in mucosal defence, inflammation and repair. Pulm Pharmacol. 1996;9:129–139
  62. Persson CG, Erjefalt JS, Greiff L, Andersson M, Erjefalt I, Godfrey RW, et al. Plasma-derived proteins in airway defence, disease and repair of epithelial injury. Eur Respir J. 1998;11:958–970
  63. Hemingson HB, Davis BE, Cockcroft DW. Seasonal fluctuations in airway responsiveness in elite endurance athletes. Can Respir J. 2004;11:399–401
  64. Helenius I, Rytilä P, Sarna S, Lumme A, Helenius M, Remes V, et al. Effect of continuing or finishing high-level sports on airway inflammation, bronchial hyperresponsiveness, and asthma: a 5-year prospective follow-up study of 42 highly trained swimmers. J Allergy Clin Immunol. 2002;109:962–968
  65. Kujala UM, Sarna S, Kaprio J. Use of medications and dietary supplements in later years among male former top-level athletes. Arch Intern Med. 2003;163:1064–1068
  66. Helenius IJ, Tikkanen HO, Sarna S, Haahtela T. Asthma and increased bronchial responsiveness in elite athletes: atopy and sport event as risk factors. J Allergy Clin Immunol. 1998;101:646–652
  67. Berger P, Walls AF, Marthan R, Tunon-de-Lara JM. Immunoglobulin E-induced passive sensitization of human airways: an immunohistochemical study. Am J Respir Crit Care Med. 1998;157:610–616
  68. Watson N, Bodtke K, Coleman RA, Dent G, Morton BE, Ruhlmann E, et al. Role of IgE in hyperresponsiveness induced by passive sensitization of human airways. Am J Respir Crit Care Med. 1997;155:839–844
  69. Mickleborough TD, Murray RL, Ionescu AA, Lindley MR. Fish oil supplementation reduces severity of exercise-induced bronchoconstriction in elite athletes. Am J Respir Crit Care Med. 2003;168:1181–1189
  70. Caillaud C, Le Creff C, Legros P, Denjean A. Strenuous exercise increases plasmatic and urinary leukotriene E4 in cyclists. Can J Appl Physiol. 2003;28:793–806
  71. Carroll NG, Mutavdzic S, James AL. Distribution and degranulation of airway mast cells in normal and asthmatic subjects. Eur Respir J. 2002;19:879–885
  72. Karjalainen E-M, Laitinen A, Sue-Chu M, Altraja A, Bjermer L, Laitinen LA. Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine. Am J Respir Crit Care Med. 2000;161:2086–2091
  73. Sue-Chu M, Henriksen AH, Bjermer L. Non-invasive evaluation of lower airway inflammation in hyper-responsive elite cross-country skiers and asthmatics. Respir Med. 1999;93:719–725
  74. Bonsignore MR, Morici G, Riccobono L, Insalaco G, Bonanno A, Profita M, et al. Airway inflammation in nonasthmatic amateur runners. Am J Physiol Lung Cell Mol Physiol. 2001;281:L668–L676
  75. Bonsignore MR, Morici G, Riccobono L, Profita M, Bonanno A, Paterno A, et al. Airway cells after swimming outdoors or in the sea in nonasthmatic athletes. Med Sci Sports Exerc. 2003;35:1146–1152
  76. Hallstrand TS, Moody MW, Wurfel MM, Schwartz LB, Henderson WR, Aitken ML. Inflammatory basis of exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 2005;172:679–686
  77. Hallstrand TS, Moody MW, Aitken ML, Henderson WR. Airway immunopathology of asthma with exercise-induced bronchoconstriction. J Allergy Clin Immunol. 2005;116:586–593
  78. Hallstrand TS, Debley JS, Farin FM, Henderson WR. Role of MUC5AC in the pathogenesis of exercise-induced bronchoconstriction. J Allergy Clin Immunol. 2007;119:1092–1098
  79. Chimenti L, Morici G, Paterno A, Bonanno A, Siena L, Licciardi A, et al. Endurance training damages small airway epithelium in mice. Am J Respir Crit Care Med. 2007;175:442–449
  80. Omori C, Schofield BH, Mitzner W, Freed AN. Hyperpnea with dry air causes time-dependent alterations in mucosal morphology and bronchovascular permeability. J Appl Physiol. 1995;78:1043–1051
  81. Hashimoto S, Gon Y, Matsumoto K, Takeshita I, Maruoka S, Horie T. Inhalant corticosteroids inhibit hyperosmolarity-induced, and cooling and rewarming-induced interleukin-8 and RANTES production by human bronchial epithelial cells. Am J Respir Crit Care Med. 2000;162:1075–1080
  82. Boulet L-P, Turcotte H, Langdeau JB, Bernier MC. Lower airway inflammatory responses to high-intensity training in athletes. Clin Invest Med. 2005;28:15–22
  83. Helenius IJ, Rytilä P, Metso T, Haahtela T, Venge P, Tikkanen HO. Respiratory symptoms, bronchial responsiveness, and cellular characteristics of induced sputum in elite swimmers. Allergy. 1998;53:346–352
  84. Nightingale JA, Rogers DF, Barnes PJ. Effect of inhaled ozone. Thorax. 1999;54:1061–1069
  85. Nieman DC, Johanssen LM, Lee JW, Arabatzis K. Infectious episodes in runners before and after the Los Angeles Marathon. J Sports Med Phys Fitness. 1990;30:316–328
  86. Gleeson M. Immune function in sport and exercise. J Appl Physiol. 2007;103:693–699
  87. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57:643–648
  88. Gibson PG, Simpson JL, Saltos N. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and increased sputum interleukin-8. Chest. 2001;119:1329–1336
  89. Anticevich SZ, Hughes JM, Black JL, Armour CL. Induction of hyperresponsiveness in human airway tissue by neutrophils—mechanism of action. Clin Exp Allergy. 1996;26:549–556
  90. Fernandes DJ, Mitchell RW, Lakser O, Dowell M, Stewart AG, Solway J. Do inflammatory mediators influence the contribution of airway smooth muscle contraction to airway hyperresponsiveness in asthma?. J Appl Physiol. 2003;95:844–853
  91. Ammit AJ, Armour CL, Black JL. Smooth-muscle myosin light chain kinase content is increased in human sensitized airways. Am J Respir Crit Care Med. 2000;161:257–263
  92. Page S, Ammit AJ, Black JL, Armour CL. Human mast cells and airway smooth muscle cell interactions: implications for asthma. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1313–L1323
  93. Bradding P, Walls AF, Holgate ST. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol. 2006;117:1277–1284
  94. Carroll NG, Mutavdzic S, James AL. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax. 2002;57:677–682
  95. Dahlén S-E, Kumlin M. Monitoring mast cell activation by prostaglandin D2 in vivo. Thorax. 2004;59:453–455
  96. Ammit AJ, Bekir SS, Johnson PR, Hughes JM, Armour CL, Black JL. Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi. Am J Respir Crit Care Med. 1997;155:1123–1129
  97. Brightling CE, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med. 2002;346:1699–1705
  98. Anticevich SZ, Hughes JM, Black JL, Armour CL. Induction of human airway hyperresponsiveness by tumor necrosis factor. Eur J Pharmacol. 1995;284:222–225
  99. Johnson PRA, Ammit AJ, Carlin SM, Armour CL, Black JL. Mast cell tryptase potentiates histamine induced contraction in human sensitised bronchi. Eur Respir J. 1996;10:38–43
  100. Watson N, Ruhlmann E, Magnussen H, Rabe KF. Histamine hypersensitivity induced by passive sensitization of human bronchus: effect of serum IgE depletion. Clin Exp Allergy. 1998;28:679–685
  101. Schmidt D, Ruehlmann E, Branscheid D, Magnussen H, Rabe KF. Passive sensitization of human airway increases responsiveness to leukotriene C4. Eur Respir J. 1999;14:315–319
  102. Kanazawa H, Asai K, Hirata K, Yoshikawa J. Vascular involvement in exercise-induced airway narrowing in patients with bronchial asthma. Chest. 2002;122:166–170
  103. Van Rensen ELJ, Hiemstra PS, Rabe KF, Sterk PJ. Assessment of microvascular leakage via sputum induction. Am J Respir Crit Care Med. 2002;165:1275–1279
  104. Kanazawa H, Hirata K, Yoshikawa J. Involvement of vascular endothelial growth factor in exercise induced bronchoconstriction in asthmatic patients. Thorax. 2002;57:885–888
  105. Kanazawa H, Tochino Y, Asai K. Angiopoietin-2 as a contributing factor of exercise-induced bronchoconstriction in asthmatic patients receiving inhaled corticosteroid therapy. J Allergy Clin Immunol. 2008;121:390–395
  106. Kanazawa H, Nomura S, Asai K. Roles of angiopoietin-1 and angiopoietin-2 on airway microvascular permeability in asthmatic patients. Chest. 2007;131:1035–1041
  107. Hermans C, Bernard A. Pneumoproteinaemia: a new perspective in the assessment of lung disorders. Eur Respir J. 1998;11:801–803
  108. Nanson CJ, Burgess JL, Robin M, Bernard AM. Exercise alters serum pneumoprotein concentrations. Respir Physiol. 2001;127:259–265
  109. Carbonnelle S, Francaux M, Doyle I, Dumont X, de Burbure C, Morel G, et al. Changes in serum pneumoproteins caused by short-term exposures to nitrogen trichloride in indoor chlorinated swimming pools. Biomarkers. 2002;7:464–478
  110. Broeckaert F, Arsalane K, Hermans C, Bergamaschi E, Brustolin A, Mutti A, et al. Serum Clara cell protein: a sensitive biomarker of increased lung epithelium permeability caused by ambient ozone. Environ Health Perspect. 2000;108:533–537
  111. Lakind JS, Holgate ST, Ownby DR, Mansur AH, Helms PJ, Pyatt D, et al. A critical review of the use of Clara cell secretory protein (CC16) as a biomarker of acute or chronic pulmonary effects. Biomarkers. 2007;12:445–467
  112. Bernard A, Carbonnelle S, Michel O, Higuet S, De Burbure C, Buchet JP, et al. Lung hyperpermeability and asthma prevalence in schoolchildren: unexpected associations with the attendance at indoor chlorinated swimming pools. Occup Environ Med. 2003;60:385–394
  113. Bernard A, Carbonnelle S, Nickmilder M, de Burbure C. Non-invasive biomarkers of pulmonary damage and inflammation: Application to children exposed to ozone and trichloramine. Toxicol Appl Pharmacol. 2005;206:185–190
  114. Bernard A, Carbonnelle S, de Burbure C, Michel O, Nickmilder M. Chlorinated pool attendance, atopy, and the risk of asthma during childhood. Environ Health Perspect. 2006;114:1567–1573
  115. Bernard A, Carbonnelle S, Dumont X, Nickmilder M. Infant swimming practice, pulmonary epithelium integrity, and the risk of allergic and respiratory diseases later in childhood. Pediatrics. 2007;119:1095–1103
  116. Freed AN, Taskar V, Schofield B, Omori C. Hyperventilation-induced airway injury and vascular leakage in dogs: effects of alpha1-adrenergic agonists. J Appl Physiol. 1997;83:1884–1889
  117. Persson CG, Erjefalt JS, Alkner U, Baumgarten CM, Greiff L, Gistafsson B, et al. Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy. 1991;21:17–24
  118. Persson CG, Andersson M, Uller L. Epithelial Repair and Function. In:  Proud D editors. The pulmonary epithelium. San Francisco: John Wiley & Sons, Ltd; 2008;
  119. Kanazawa H. Microvascular theory of exercise-induced bronchoconstriction in asthma: potential implication of vascular endothelial growth factor. Inflamm Allergy Drug Targets. 2007;6:133–137
  120. Anderson SD, Daviskas E. The airway microvasculature and exercise-induced asthma. Thorax. 1992;47:748–752
  121. Naline E, Devillier P, Drapeau G, Toty L, Bakdach H, Regoli D, et al. Characterization of neurokinin effects and receptor selectivity in human isolated bronchi. Am Rev Respir Dis. 1989;140:679–686
  122. Frossard N, Rhoden KJ, Barnes PJ. Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. J Pharmacol Exp Ther. 1989;248:292–298
  123. Joos GF, Vincken W, Louis R, Schelfhout VJ, Wang JH, Shaw MJ, et al. Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients. Eur Respir J. 2004;23:76–81
  124. Solway J, Leff AR. Sensory neuropeptides and airway function. J Appl Physiol. 1991;71:2077–2087
  125. Nagase T, Ohga E, Katayama H, Sudo E, Aoki T, Matsuse T, et al. Roles of calcitonin gene-related peptide (CGRP) in hyperpnea-induced constriction in guinea pigs. Am J Respir Crit Care Med. 1996;154:1551–1556
  126. Crimi N, Mastruzzo C, Pagano C, Lisitano N, Palermo F, Vancheri C. Montelukast protects against bradykinin-induced bronchospasm. J Allergy Clin Immunol. 2005;115:870–872
  127. Hallstrand TS, Chi EY, Singer AG, Gelb MH, Henderson WR. Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2007;176:1072–1078
  128. Hilberg T. Etiology of exercise-induced asthma: physical stress-induced transcription. Curr Allergy Asthma Rep. 2007;7:27–32
  129. Mickleborough TD, Lindley MR, Ionescu AA, Fly AD. Protective effect of fish oil supplementation on exercise-induced bronchoconstriction in asthma. Chest. 2006;129:39–49
  130. Kemp JP, Dockhorn RJ, Shapiro GG, Nguyen HH, Reiss TF, Seidenberg BC, et al. Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr. 1998;133:424–428
  131. Baki A, Orhan F. The effect of loratadine in exercise-induced asthma. Arch Dis Child. 2002;86:38–39
  132. Coreno A, Skowronski M, Kotaur C, McFadden ER. Comparative effects of long-acting β2-agonists, leukotriene antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. J Allergy Clin Immunol. 2000;106:500–506
  133. Fischer AR, McFadden CA, Frantz R, Awni WM, Cohn J, Drazen JM, et al. Effect of chronic 5-lipozygenase inhibition on airway hyperresponsiveness in asthmatic subjects. Am J Respir Crit Care Med. 1995;152:1203–1207
  134. Gulliksson M, Brunnstrom A, Johannesson M, Backman L, Nilsson G, Harvima I, et al. Expression of 15-lipoxygenase type-1 in human mast cells. Biochim Biophys Acta. 2007;1771:1156–1165
  135. Hwang SW, Cho H, Kwak J, Lee SY, Kang CJ, Jung J, et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci U S A. 2000;97:6155–6160
  136. Banner AS, Green J, O'Connor M. Relation of respiratory water loss to coughing after exercise. N Engl J Med. 1984;311:883–886
  137. van der Woude HJ, Winter TH, Aalbers R. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long action β2 agonists. Thorax. 2001;56:529–535
  138. Anderson SD, Fitch K, Perry CP, Sue-Chu M, Crapo R, McKenzie D, et al. Responses to bronchial challenge submitted for approval to use inhaled beta2 agonists prior to an event at the 2002 Winter Olympics. J Allergy Clin Immunol. 2003;111:44–49
  139. Anderson SD, Brannan JD. Long-acting beta2-adrenoceptor agonists and exercise-induced asthma: lessons to guide us in the future. Paediatr Drugs. 2004;6:161–175
  140. Storms W, Chervinsky P, Ghannam AF, Bird S, Hustad CM, Edelman JM. A comparison of the effects of oral montelukast and inhaled salmeterol on response to rescue bronchodilation after challenge. Respir Med. 2004;98:1051–1062
  141. Anderson SD, Caillaud C, Brannan JD. β2-agonists and exercise-induced asthma. Clin Rev Allergy Immunol. 2006;31:163–180
  142. Anderson SD, Sue-Chu M, Perry CP, Gratziou C, Kippelen P, McKenzie DC, et al. Bronchial challenges in athletes applying to inhale a β2-agonist at the 2004 summer Olympics. J Allergy Clin Immunol. 2006;117:767–773
  143. Weinberger M, Abu-Hasan M. Life-threatening asthma during treatment with salmeterol. N Engl J Med. 2006;355:852–853
  144. Kay LJ, Rostami-Hodjegan A, Suvarna SK, Peachell PT. Influence of beta2-adrenoceptor gene polymorphisms on beta2-adrenoceptor-mediated responses in human lung mast cells. Br J Pharmacol. 2007;152:323–331
  145. Hancox RJ, Subbarao P, Kamada D, Watson RM, Hargreave FE, Inman MD. Beta2-agonist tolerance and exercise-induced bronchospasm. Am J Respir Crit Care Med. 2002;165:1068–1070
  146. Haney S, Hancox RJ. Rapid onset of tolerance to beta-agonist bronchodilation. Respir Med. 2005;99:566–571
  147. Davis BE, Reid JK, Cockcroft DW. Formoterol thrice weekly does not result in the development of tolerance to bronchoprotection. Can Respir J. 2003;10:23–26
  148. Johnson M. Molecular mechanisms of β2 adrenergic receptor function, response and regulation. J Allergy Clin Immunol. 2006;117:18–24
  149. Baluk P, McDonald DM. The beta 2-adrenergic receptor agonist formoterol reduces microvascular leakage by inhibiting endothelial gap formation. Am J Physiol Lung Cell Mol Physiol. 1994;266:L461–L468
  150. Chetta A, Zanini A, Olivieri D. Therapeutic approach to vascular remodelling in asthma. Pulm Pharmacol Ther. 2007;20:1–8
  151. Omori C, Schofield BH, Mitzner W, Freed AN. A β2-adrenergic agonist inhibits dry air-induced injury in canine peripheral airways. J Appl Physiol. 1995;78:2169–2179
  152. Greiff L, Wollmer P, Andersson M, Svensson C, Persson CG. Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects. Thorax. 1998;53:1010–1013
  153. Haney S, Hancox RJ. Recovery from bronchoconstriction and bronchodilator tolerance. Clin Rev Allergy Immunol. 2006;31:181–196
  154. Cockcroft DW. Inhaled β2-agonists and airway responses to allergen. J Allergy Clin Immunol. 1998;102(suppl):S96–S99
  155. Swystun VA, Gordon JR, Davis EB, Zhand X, Cockcroft DW. Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol. 2000;106:57–64
  156. Evans DW, Salome CM, King GG, Rimmer SJ, Seale JP, Woolcock AJ. Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects. Thorax. 1997;52:136–142
  157. Gauvreau GM, Jordana M, Watson RM, Cockcroft DW, O'Byrne PM. Effect of regular inhaled albuterol on allergen induced late responses and sputum eosinophils in asthmatic subjects. Am J Respir Crit Care Med. 1997;156:1738–1745
  158. Mak JCW, Roffel F, Katsunuma T, Elzinga CRS, Zaagsma J, Barnes PJ. Up-regulation of airway smooth muscle histamine H1 receptor mRNA, protein, and function by beta 2-adrenoceptor activation. Mol Pharmacol. 2000;57:857–864
  159. McGraw DW, Almoosa KF, Paul RJ, Kobilka BK, Liggett SB. Antithetic regulation by beta-adrenergic receptors of Gq receptor signaling via phospholipase C underlies the airway beta-agonist paradox. J Clin Invest. 2003;112:619–626
  160. McGraw DW, Liggett SB. Molecular mechanisms of beta2-adrenergic receptor function and regulation. Proc Am Thorac Soc. 2005;2:292–296discussion 311-2
  161. Anderson GP. Current issues with β2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms. Clin Rev Allergy Immunol. 2006;31:119–130
  162. McGraw DW, Elwing JM, Fogel KM, Wang WCH, Glinka CB, Muihlbachler KA, et al. Cross talk between Gi and Gq/Gs pathways in airway smooth muscle regulates bronchial contractility and relaxation. J Clin Invest. 2007;117:1391–1398

 Series editors: Donald Y. M. Leung, MD, PhD, and Dennis K. Ledford, MD

 Supported by the National Health and Medical Research Council of Australia.

PII: S0091-6749(08)00785-9

doi: 10.1016/j.jaci.2008.05.001

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 2 , Pages 225-235 , August 2008

Article Tools

* Image Usage & Resolution